CDC National Vaccine Program Office: National Vaccine Advisory Committee: Resolution: US Vaccine Industry

National Vaccine Program Office

About NVPO

What's New

Vaccine Conference

NVAC Report: Strengthening the Supply of Vaccines in the U.S.

Calendar

Citation
Information

Immunization
Glossary

Immunization
Registries

Registry Support for
Immunization
Programs

Progress
Report

Immunization
Registry
Clearinghouse

Influenza

Influenza (flu)
Season 2003-2004

Pandemic Influenza

National Vaccine Plan

NVAC

NVAC Resolutions

Meeting Materials

Publications

Public Health
Emergency
Preparedness and
Response

Severe Acute
Respiratory
Syndrome

Smallpox Planning
and Response

Research

Unmet Needs Projects

Vaccine Fact Sheets

What You Need
to Know

Immunization
Concepts

Immunization
Laws

If We Stop
Vaccinating

Vaccine Safety

Q&A

Some of the People
Who Stand Behind
Vaccinations

10 Tips on Evaluating
  Immunization
  Information on
  the Internet

Wild Poliovirus
Laboratory
Containment

Travelers' Health

Welcome Center

NATIONAL VACCINE ADVISORY COMMITTEE

Resolution:

United States Vaccine Industry – Mercer Report

May 11, 1995

Resolution made by Dr. Douglas:

We, the National Vaccine Advisory Committee, recommend to the Director, National Vaccine Program, that Mercer Consultants be instructed to examine the data of their recent report, and evaluate the effect of differing scenarios regarding the relative loss of private market due to the Vaccines for Children program and on vaccine company revenues on research and development.

Welcome Center | What's New | Publications | Contact Us

CDC Home | Search | Health Topics A-Z

Last updated: August 8, 2003
URL:

Centers for Disease Control and Prevention
National Vaccine Program Office